ASX - By Stock
|
BOT |
Re:
Sofdra - Post approval royalties, costs and earnings
|
|
camviv
|
31 |
6.2K |
4 |
11:49 |
11:49 |
ASX - By Stock
|
31
|
6.2K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
6 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
12K
|
4.2M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
42 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
42
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Included in the All Ordinaries Index
|
|
camviv
|
38 |
10K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
10K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Included in the All Ordinaries Index
|
|
camviv
|
38 |
10K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
38
|
10K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
26 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
26
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
12 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12K
|
4.2M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12K
|
4.2M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
6 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
7 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix to Present at Euroz Hartleys Conference
|
|
camviv
|
112 |
28K |
7 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
112
|
28K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix to Present at Euroz Hartleys Conference
|
|
camviv
|
112 |
28K |
9 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
112
|
28K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
4 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
8 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
8 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: NDA Resubmission Accepted and Approval Date Confirmed
|
|
camviv
|
112 |
35K |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
112
|
35K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: NDA Resubmission Accepted and Approval Date Confirmed
|
|
camviv
|
112 |
35K |
7 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
112
|
35K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
6 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
7 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
8 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
12K
|
4.2M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Successful Completion of Human Factors Study
|
|
camviv
|
52 |
14K |
4 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
52
|
14K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Sofdra write up on *
|
|
camviv
|
6 |
2.4K |
3 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
6
|
2.4K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Confirms Approach to Sofdra NDA Resubmission
|
|
camviv
|
81 |
21K |
3 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
81
|
21K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
11 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
12K
|
4.2M
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Confirms Approach to Sofdra NDA Resubmission
|
|
camviv
|
81 |
21K |
11 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
81
|
21K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
11 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
12K
|
4.2M
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
12 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
12K
|
4.2M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
17 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
17
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
5 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: September 2023 Quarterly Activities Report and Appendix 4C
|
|
camviv
|
46 |
9.6K |
4 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
46
|
9.6K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
7 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
13 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
6 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
12K
|
4.2M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
7 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Application for quotation of securities - BOT
|
|
camviv
|
5 |
1.8K |
3 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
5
|
1.8K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
14 |
08/10/23 |
08/10/23 |
ASX - By Stock
|
12K
|
4.2M
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
camviv
|
295 |
75K |
7 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
295
|
75K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation- FDA Letter Requires Patient Instruction Update
|
|
camviv
|
68 |
15K |
6 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
68
|
15K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
camviv
|
316 |
89K |
4 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
316
|
89K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BOT Submits FDA New Drug Application for Sofpironium Bromide
|
|
camviv
|
172 |
62K |
8 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
172
|
62K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.0K |
2.9M |
8 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
12K |
4.2M |
13 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
12K
|
4.2M
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Letter to Shareholders - Notice of General Meeting
|
|
camviv
|
26 |
11K |
7 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
26
|
11K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Post-FDA decision price sweep
|
|
camviv
|
124 |
34K |
4 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
124
|
34K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Post-FDA decision price sweep
|
|
camviv
|
124 |
34K |
2 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
124
|
34K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Post-FDA decision price sweep
|
|
camviv
|
124 |
34K |
19 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
124
|
34K
|
19
|
|